nsecticide resistance in mosquitoes has become a severe impediment to global vector control, and manifests as decreased insecticide effectiveness. The role of target site mutations and detoxification
Abl kinase inhibitors targeting the ATP binding pocket are currently employed as potent anti-leukemogenic agents but drug resistance has become a significant clinical limitation. Recently, a compound
